MNOV · Medicinova Inc
United States · RS rating 48 · As of 2026-11-03
| Price | 1.42 USD |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 48 / 22 / 78 / 40 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 30 / 34 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +23.1% |
| Distance from 52-week high | +58.8% |
| Market cap (USD) | $67.4M |